Sonnweber T, Grubwieser P, Sahanic S, Bohm A, Pizzini A, Luger A
Metabolites. 2022; 12(6).
PMID: 35736479
PMC: 9228477.
DOI: 10.3390/metabo12060546.
Liu M, Hu R, Li W, Yang W, Xu Q, Chen L
Front Microbiol. 2022; 13:834477.
PMID: 35495646
PMC: 9039748.
DOI: 10.3389/fmicb.2022.834477.
Athira P, Anooja V, Anju M, Neelima S, Archana K, Musthafa S
J Genet Eng Biotechnol. 2022; 20(1):49.
PMID: 35344090
PMC: 8960508.
DOI: 10.1186/s43141-022-00330-7.
Viveiros A, Panzer M, Baumgartner N, Schaefer B, Finkenstedt A, Henninger B
Liver Int. 2020; 40(8):1941-1951.
PMID: 32450003
PMC: 7496278.
DOI: 10.1111/liv.14539.
Liu J, Fan Y, Yang Z, Wang Z, Guo C
Front Neurosci. 2018; 12:632.
PMID: 30250423
PMC: 6139360.
DOI: 10.3389/fnins.2018.00632.
Identification of Antibody and Small Molecule Antagonists of Ferroportin-Hepcidin Interaction.
Ross S, Biswas K, Rottman J, Allen J, Long J, Miranda L
Front Pharmacol. 2017; 8:838.
PMID: 29209212
PMC: 5702341.
DOI: 10.3389/fphar.2017.00838.
Prophylactic Iron Supplementation in Pregnancy: A Controversial Issue.
Friedrisch J, Friedrisch B
Biochem Insights. 2017; 10:1178626417737738.
PMID: 29123406
PMC: 5661664.
DOI: 10.1177/1178626417737738.
The three isoforms of hepcidin in human serum and their processing determined by liquid chromatography-tandem mass spectrometry (LC-tandem MS).
Addo L, Ikuta K, Tanaka H, Toki Y, Hatayama M, Yamamoto M
Int J Hematol. 2015; 103(1):34-43.
PMID: 26462810
DOI: 10.1007/s12185-015-1885-y.
Ironing out Ferroportin.
Drakesmith H, Nemeth E, Ganz T
Cell Metab. 2015; 22(5):777-87.
PMID: 26437604
PMC: 4635047.
DOI: 10.1016/j.cmet.2015.09.006.
Insights into the antimicrobial properties of hepcidins: advantages and drawbacks as potential therapeutic agents.
Lombardi L, Maisetta G, Batoni G, Tavanti A
Molecules. 2015; 20(4):6319-41.
PMID: 25867823
PMC: 6272296.
DOI: 10.3390/molecules20046319.
Iron-refractory iron deficiency anemia.
Keskin E, Yenicesu I
Turk J Haematol. 2015; 32(1):1-14.
PMID: 25805669
PMC: 4439901.
DOI: 10.4274/tjh.2014.0288.
Neuroprotective effect of the active components of three Chinese herbs on brain iron load in a mouse model of Alzheimer's disease.
Dong X, Gao W, Kong W, Xie H, Peng Y, Shao T
Exp Ther Med. 2015; 9(4):1319-1327.
PMID: 25780429
PMC: 4353762.
DOI: 10.3892/etm.2015.2234.
Low intracellular iron increases the stability of matriptase-2.
Zhao N, Nizzi C, Anderson S, Wang J, Ueno A, Tsukamoto H
J Biol Chem. 2015; 290(7):4432-46.
PMID: 25550162
PMC: 4326848.
DOI: 10.1074/jbc.M114.611913.
Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy.
McCarthy R, Kosman D
Cell Mol Life Sci. 2014; 72(4):709-27.
PMID: 25355056
PMC: 4312246.
DOI: 10.1007/s00018-014-1771-4.
A novel model for brain iron uptake: introducing the concept of regulation.
Simpson I, Ponnuru P, Klinger M, Myers R, Devraj K, Coe C
J Cereb Blood Flow Metab. 2014; 35(1):48-57.
PMID: 25315861
PMC: 4294394.
DOI: 10.1038/jcbfm.2014.168.
Prolactin (PRL)-stimulated ubiquitination of ZnT2 mediates a transient increase in zinc secretion followed by ZnT2 degradation in mammary epithelial cells.
Seo Y, Lee S, Hennigar S, Kelleher S
J Biol Chem. 2014; 289(34):23653-61.
PMID: 25016022
PMC: 4156067.
DOI: 10.1074/jbc.M113.531145.
Ceruloplasmin-ferroportin system of iron traffic in vertebrates.
Musci G, Polticelli F, Bonaccorsi di Patti M
World J Biol Chem. 2014; 5(2):204-15.
PMID: 24921009
PMC: 4050113.
DOI: 10.4331/wjbc.v5.i2.204.
Nanopore film based enrichment and quantification of low abundance hepcidin from human bodily fluids.
Fan J, Niu S, Dong A, Shi J, Wu H, Fine D
Nanomedicine. 2014; 10(5):879-88.
PMID: 24566273
PMC: 4077980.
DOI: 10.1016/j.nano.2014.02.005.
Hepcidin in neoplastic disease.
Nicolae C, Coman O, Ene C, Nicolae I, Fulga I
J Med Life. 2013; 6(3):355-60.
PMID: 24146699
PMC: 3786499.
Hepcidin bound to α2-macroglobulin reduces ferroportin-1 expression and enhances its activity at reducing serum iron levels.
Huang M, Austin C, Sari M, Suryo Rahmanto Y, Ponka P, Vyoral D
J Biol Chem. 2013; 288(35):25450-25465.
PMID: 23846698
PMC: 3757207.
DOI: 10.1074/jbc.M113.471573.